Navigation Links
Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
Date:4/14/2009

new surgical strategy by reconstructing the anulus and anchoring it to the vertebral body for a more secure solution. Intrinsic and the surgeons we serve are very excited by the positive results from the initial clinical study of the Barricaid that helped us reach this important milestone."

About Intrinsic Therapeutics

Intrinsic Therapeutics is dedicated to treating soft-tissue injuries of the spine. Intrinsic's Barricaid anular reconstructive products are used during discectomy to definitively close defects in the posterior anulus. By restoring anular competence, the Barricaid family of products may reduce the risk of recurrent herniation while maintaining disc height and biomechanics.

    Contacts:
    Scott LeBlanc                               Tom Guest
    Director Finance                            VP Sales & Marketing
    Intrinsic Therapeutics, Inc.                Intrinsic Therapeutics, Inc.
    781-932-0222 ext. 173                       781-932-0222 ext. 133
    finance@in-thera.com


'/>"/>
SOURCE Intrinsic Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... New York, NY (PRWEB) May 22, 2015 ... abstract entitled “Positivity Rates and Genotype Results in ‘Baby ... Action: Results from a Nationwide Lab Test Database” at Digestive ... conducted by Medivo’s Clinical Affairs and Analytics team members Carol ... Dhaliwal, MD; and Andrea Parker, MSI, along with Nancy Reau, ...
(Date:5/22/2015)... DMG Productions announces the upcoming airing of Innovations ... May 29, 2015 at 7:30 a.m. ET and 7:30 ... Innovations will explore Interstate Restoration, a company dedicated to ... recovery and restoration. , Additionally, the series will focus ... and deliver training and education in the areas of ...
(Date:5/22/2015)... 2015 In April 2006, Veatch Consulting ... 9 years they have concentrated their focus to working ... Canada. Because of this growth and their goals to ... in Denver, Colorado, Cleveland, Ohio, Houston, Texas and now ... new dental offices, dental start ups, orthodontic practices, pediatric ...
(Date:5/22/2015)... May 22, 2015 Puritan Medical ... for the medical, diagnostic, environmental, and forensics industries ... of products in the US. At a time ... outside the US, Puritan remains committed to designing ... their Guilford, Maine facility. , Since 1919, Puritan ...
(Date:5/22/2015)... Viejo, CA (PRWEB) May 22, 2015 ... editable lower thirds designed exclusively for Final Cut Pro ... compatible with any design. , Intuitive on-screen-controls allow ... unique lower third. Reflections, colors, layouts, and much more ... Inspector window. , Pro3rd Impression comes ...
Breaking Medicine News(10 mins):Health News:Medivo Study Finds HCV Positivity Rates are 250% Higher Among Baby Boomers 2Health News:New Episode of Innovations Airing Friday, May 29, 2015 Via Discovery Channel 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Developers at Pixel Film Studios Release Pro3rd Impression for Final Cut Pro X. 2
... , CUPERTINO, Calif., July 27 ... quarter 2009 financial results press release, you are invited to listen ... internet on Monday, August 3, 2009 at 4:30 pm Eastern Time ... http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO ) , , A live audio webcast ...
... of serious complications drop with intensive therapy, study shows ... controlling blood sugar levels and taking medications that lower ... can significantly reduce their risk of developing the most ... , In a study appearing in the July 27 ...
... 27 Danaher Corporation (NYSE: DHR ) announced today that ... effective as of the end of 2009. , , ... joining Danaher in 2000. , , "Phil ... portfolio over the past nine years," said H. Lawrence Culp, Jr., President ...
... , , ATLANTA, July 27 ... diagnosis and treatment of infertility with ovulation induction and insemination, surgery ... financial aspects. Discussions include information about age related infertility, fallopian tube ... donor eggs. , , You will also ...
... , , , ... Program officials announced today that Tennessee residents have saved over ... launch of the free statewide prescription assistance program. Tennessee Drug ... in May 2007. The program has no restrictions to membership, no ...
... , , MINNEAPOLIS, July 27 ... the world,s population, often resulting in patches of dry skin, and little ... in the teenage years but may continue throughout adulthood. There is ... Alan B. Fleischer, professor and chair of the department of dermatology at ...
Cached Medicine News:Health News:DURECT Corporation Invites You to Join Its Second Quarter 2009 Earnings Conference Call 2Health News:Tight Management of Type 1 Diabetes Worth the Effort 2Health News:Tight Management of Type 1 Diabetes Worth the Effort 3Health News:Tennessee Drug Card Has Saved Residents Over $7.3 Million 2Health News:What Is Keratosis Pilaris (KP)? 2
(Date:5/22/2015)... WASHINGTON , May 22, 2015  The ... certain diagnosed victims of mesothelioma get the best ... making certain individuals with this rare cancer caused ... the most up-to-date information related to treatment options ... information please call the Mesothelioma Victims Center anytime ...
(Date:5/22/2015)... --  InspireMD, Inc. (NYSE MKT: NSPR) ("InspireMD" or the ... announced that its CGuard TM Embolic Prevention System reported ... Piotr Musialek , at the EuroPCR conference on ... PARADIGM, an investigator-initiated P rospective evaluation of ... revascularization I n symptomatic and increased-risk asymptomatic carotid ...
(Date:5/22/2015)... , May 22, 2015  In a sweeping ... the U.S., T1D Exchange researchers conclude that ... type 1 diabetes across all age groups, but especially ... most up-to-date picture of diabetes treatment, underscoring the need ... and technologies that can help type 1 patients achieve ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 2InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 3InspireMD's CGuardTM Highlighted at Clinical Presentation at EuroPCR 2015 Conference 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5
... In a platform presentation at the 46th annual meeting ... (EASD) in Stockholm, investigators for Biodel Inc. (Nasdaq: ... clinical study evaluating a new pH-neutral formulation of Linjeta™ ... Research, Neuss, Germany) and colleagues reported that the new ...
... (Nasdaq: MYL ) today announced that its ... the U.S. Food and Drug Administration (FDA) for its ... mg, 1 mg and 5 mg, the generic version ... in people who have received certain organ transplants. ...
Cached Medicine Technology:Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting 2Results of Linjeta™ Study Versus Insulin Lispro Reported Today in Platform Presentation at EASD Annual Meeting 3
... SurgiGraphic 1027, with a Carbon Fiber ... designed for superior C-arm access, safety ... design means C-Arm utilization is quick ... exposure is minimized resulting in a ...
... The SurgiGraphic 6000 ... the tabletop for precise ... Float allows for immediate ... moving the C-Arm, making ...
... IMPLANT SYSTEM is a unique three-piece implant ... 1st metatarsal phalangeal joint resulting from osteoarthritis, ... a previous arthroplasty. The implant is ... superior function and longevity. With a ...
... play an important part in our daily ... rheumatic changes can cause severe handicaps. A ... finger-joint prostheses was to produce a reconstructed ... function as nearly possible.,The cementless RM Finger ...
Medicine Products: